India’s New GST Tax A Game Changer For Pharma But Challenges Ahead

India’s ambitious new Goods and Services Tax, aimed at turning the country into a single common market, will be a ‘game-changer’ with a mix of impacts for the pharma industry and the rest of the economy, but the rollout involves overcoming considerable logistical challenges.